When harms outweigh benefits of long-term opioid therapy for pain: Need for a new diagnostic entity, research and improved treatments
- PMID: 37766414
- DOI: 10.1111/add.16348
When harms outweigh benefits of long-term opioid therapy for pain: Need for a new diagnostic entity, research and improved treatments
Keywords: analgesics; chronic pain; diagnosis; guideline-concordant care; opioid-related disorders; opioids.
References
REFERENCES
-
- Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276-286. https://doi.org/10.7326/M14-2559
-
- Sandbrink F, Murphy JL, Johansson M, Olson JL, Edens E, Clinton-Lont J, et al. The use of opioids in the management of chronic pain: synopsis of the 2022 updated US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline. Ann Intern Med. 2023;176(3):388-397. https://doi.org/10.7326/M22-2917
-
- Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain-United States, 2022. MMWR Recommendations and Reports. 2022;71(3):1-95. https://doi.org/10.15585/mmwr.rr7103a1
-
- Edmond SN, Snow JL, Pomeranz J, van Cleve R, Black AC, Compton P, et al. Delphi study to explore a new diagnosis for “ineffective” long-term opioid therapy for chronic pain. Pain. 2023;164(4):870-876. https://doi.org/10.1097/j.pain.0000000000002783
-
- Edmond SN, Snow JL, Pomeranz J, Van Cleve R, Becker WC. Arguments for and against a new diagnostic entity for patients with chronic pain on long-term opioid therapy for whom harms outweigh benefits. J Pain. 2022;23(6):958-966. https://doi.org/10.1016/j.jpain.2021.12.006
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
